‘Upgrade Quality or Risk Shutdowns’, DCGI
Source: News18 India’s pharmaceutical industry has undergone a comprehensive regulatory overhaul spearheaded by the nation’s apex health regulatory agency and its chief, the Drug Controller General of India (DCGI), amid quality concerns raised by global regulators. Throughout the year, DCGI Rajeev Singh Raghuvanshi made headlines for his several moves, ranging from aggressive raids on pharmaceutical […]